European Committee for Standardization

The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union

Retrieved on: 
Monday, December 11, 2023
CNS, Lung, Health, Neck, Prostate, Medical University of Vienna, Breast, Brain, Safety, Food, European Medicines Agency, Paediatric-use marketing authorisation, European Commission, Head, University, Medical imaging, Human, Liver, Spine, GBCA, Google Images, PICTURE, Gadolinium, EMA, Civil service commission, Patient, Marketing authorisation, European, Gadobutrol, Neurology, FDA, Kidney, Pancreas, European Committee for Standardization, CHMP, BBB, Monroe Dunaway Anderson, Committee, Pathology, Gastroenterology, MRI, Central nervous system, MD Anderson Cancer Center, Medical school, Environment, Vaccine, Rare-earth element

Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union.

Key Points: 
  • Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union.
  • MILAN, Dec. 11, 2023 /PRNewswire/ -- Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of precision diagnostic imaging modalities, announces that on December 7, 2023 the European Commission (EC) has granted the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union (EU).
  • 1,2
    "The final approval of gadopiclenol by the European Commission marks a significant milestone in the field of diagnostic imaging.
  • This innovation benefits healthcare providers but also, more importantly, patients who undergo MRI scans and those living with chronic conditions.

The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union

Retrieved on: 
Monday, December 11, 2023
CNS, Lung, Health, Neck, Prostate, Medical University of Vienna, Breast, Brain, Safety, Food, European Medicines Agency, Paediatric-use marketing authorisation, European Commission, Head, University, Medical imaging, Human, Liver, Spine, GBCA, Google Images, PICTURE, Gadolinium, EMA, Civil service commission, Patient, Marketing authorisation, European, Gadobutrol, Neurology, FDA, Kidney, Pancreas, European Committee for Standardization, CHMP, BBB, Monroe Dunaway Anderson, Committee, Pathology, Gastroenterology, MRI, Central nervous system, MD Anderson Cancer Center, Medical school, Environment, Vaccine, Rare-earth element

Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union.

Key Points: 
  • Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union.
  • MILAN, Dec. 11, 2023 /PRNewswire/ -- Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of precision diagnostic imaging modalities, announces that on December 7, 2023 the European Commission (EC) has granted the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union (EU).
  • 1,2
    "The final approval of gadopiclenol by the European Commission marks a significant milestone in the field of diagnostic imaging.
  • This innovation benefits healthcare providers but also, more importantly, patients who undergo MRI scans and those living with chronic conditions.

Dawex, Fraunhofer ISST and TNO Agree to co-Propose a Pre-Standardization Program on Trusted Data Transaction

Retrieved on: 
Wednesday, February 8, 2023
Data Management, Security, Apps, Applications, Technology, Software, Networks, Internet, Organization, Element, Fraunhofer, ICT Group, CEN, European Committee for Standardization, Fraunhofer Society, Luigi, Trust, TNO, ICT, Trusted Data Format, Policy, Cryptocurrency, Information technology

Trust is a cornerstone of data exchange as it cements the relationship and drives collaboration between all parties involved in the data transactions.

Key Points: 
  • Trust is a cornerstone of data exchange as it cements the relationship and drives collaboration between all parties involved in the data transactions.
  • To better understand the scope and implications of the expression of “Trusted Data Transaction” and anticipate future associated standardization requirements, a European Committee for Standardization (CEN) workshop program is being kicked off.
  • This structuring program will provide guiding principles to organizations looking at building strong data spaces in a trustworthy data economy,” said Prof. Dr.-Ing.
  • Boris Otto, Chairman of the Fraunhofer ICT Group and Executive Director of the Fraunhofer Institute for Software and Systems Engineering ISST.

IOR double anniversary event celebrates the history of ammonia vapour compression refrigeration

Retrieved on: 
Wednesday, November 2, 2022
Zero, Face, Life, Mechanical, The, International Institute of Refrigeration, European Committee for Standardization, Balochistan University of Engineering and Technology, IOR, Efficiency, International Organization for Standardization, Society, Industry, CEN, BSI, Institute, Cold storage, ISO, Book, Invention, 150th anniversary of Canada, Technology, Adoption, Internet Technical Committee, American National Standards Institute, Food, History, Carbon, American Society of Mechanical Engineers, Mechanical engineering, Woman, Boyle, Man, Industrial gas, Heating, ventilation, and air conditioning, Ammonia, Refrigeration

GLASGOW, United Kingdom, Nov. 2, 2022 /PRNewswire-PRWeb/ -- Celebrate the 150th anniversary of the world's first ammonia refrigeration system using vapour compression and discover the exciting story surrounding the developments that spawned the widespread use of one of the most climate-friendly refrigerants at an informative online webinar organised by the Institute of Refrigeration on 3rd November at 4:30 pm.

Key Points: 
  • Two top cooling experts will present innovative research on the history of ammonia vapour compression at a webinar hosted by the Institute of Refrigeration (IOR) to commemorate its 123rd year.
  • Spotlighting the life, sacrifices, and sheer determination of inventors such as David Boyle of the Boyle Ice Machine company, to whom the commercial success of ice machines based on the compression of ammonia vapour is attributed, the event will track the history of ammonia vapour compression technology from its inception in the 1870s.
  • Evaluating the successes and blunders in ammonia vapour compression's history offers the opportunity to understand the significant technical developments that were required to make ammonia compression cooling systems safe, efficient and reliable to ultimately change the face of modern refrigeration.
  • The extensive use of ammonia as a refrigerant is linked to developing vapour compression as the preferred method of achieving mechanical refrigeration.

France Elevator and Escalator Market Report 2022-2027 - Grand Paris Project and the 2024 Olympic Games in Paris are Expected to Propel the Elevator Market Forward - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022
Building Systems, Interior Design, Other Construction & Property, Commercial Building & Real Estate, Construction & Property, Safety, Adoption, City, SMART, Kohler, Grand Paris Express, Population, Spokane Public Facilities District, European Committee for Standardization, Investment, Hyundai, Person, Les Roches Jin Jiang International Hotel Management College, Otis Worldwide, Government, Metropolis, Mitsubishi Electric, TKE, Standardization, Urbanization, Ageing, Olympic Games, Fujitec, Transport, Athlete, Tourism, Seine-Saint-Denis, Technology, Toshiba, Internet, Housing, Hitachi, Grand Paris, Renewable energy, Restaurant, Elevator, Rail transport, Greater Paris, Otis

The increasing number of the aging population has paved the path for tremendous expansion in the elevator and escalator industry.

Key Points: 
  • The increasing number of the aging population has paved the path for tremendous expansion in the elevator and escalator industry.
  • The Grand Paris Project and the 2024 Olympic Games in Paris are expected to propel the elevator market forward.
  • The demand for elevator security in France and other European countries is a primary driver of the elevator market.
  • The key players in France's Elevator & Escalator market are KONE, Otis, Hyundai Elevator TKE, Schindler, Mitsubishi Electric, Hitachi, Toshiba, Fujitec, and Kohler.

Inhance Technologies Announces its Enkase® Technology Does Not Impart LCPFACs to HDPE Packaging

Retrieved on: 
Monday, March 21, 2022
Glass, Plastic, PFAS, Environment, European Committee for Standardization, Laboratory, Agriculture, HDPE, Technology, EPA, Solution, Electronics, CFR, FDA, CEN, Recycling

HOUSTON, Texas, March 21, 2022 /PRNewswire/ -- Inhance Technologies is pleased to announce that its Enkase barrier technology does not impart long-chain perfluoroalkyl carboxylate (LCPFAC) chemical substances to high-density polyethylene (HDPE) packaging.

Key Points: 
  • HOUSTON, Texas, March 21, 2022 /PRNewswire/ -- Inhance Technologies is pleased to announce that its Enkase barrier technology does not impart long-chain perfluoroalkyl carboxylate (LCPFAC) chemical substances to high-density polyethylene (HDPE) packaging.
  • Inhance Technologies, a leading global provider of sustainable specialty chemicals and materials technologies, remains dedicated to continuously developing and implementing innovative technologies that preserve and protect the environment.
  • As always, Enkase imparts a permanent barrier to HDPE packaging regardless of its shape, size or design.
  • Inhance Technologies is a global leading provider of sustainable specialty chemicals and materials technologies.

Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer

Retrieved on: 
Tuesday, January 4, 2022
EMA, Royal commission, CHMP, Cardiotoxicity, Committee for Medicinal Products for Human Use, Critical care, Survival, Health, Bevacizumab, Physician, News, CEO, Oxaliplatin, European Medicines Agency, European Committee for Standardization, Acral lentiginous melanoma, Pulmonary toxicity, Patient, Rheumatology, EC, Committee, Colorectal cancer, Irinotecan, European Commission, Pharmaceutical industry, Vaccine, Tegafur/gimeracil/oteracil

In metastatic colorectal cancer, the typical first-line chemotherapy contains of a fluoropyrimidine used in various combinations.

Key Points: 
  • In metastatic colorectal cancer, the typical first-line chemotherapy contains of a fluoropyrimidine used in various combinations.
  • Jean-Michel Quinot, CEO of Nordic Pharma stated: "This is important news for patients with metastatic colorectal cancer.
  • Iris van Lakerveld, Global Oncology Lead added: "Fluoropyrimidines are, and will continue to be, the cornerstone of chemotherapy treatment in metastatic colorectal cancer.
  • This positive CHMP opinion is a first step in providing patients with metastatic colorectal cancer access to Teysuno.

Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer

Retrieved on: 
Tuesday, January 4, 2022
EMA, Royal commission, CHMP, Cardiotoxicity, Committee for Medicinal Products for Human Use, Critical care, Survival, Health, Bevacizumab, Physician, News, CEO, Oxaliplatin, European Medicines Agency, European Committee for Standardization, Acral lentiginous melanoma, Pulmonary toxicity, Patient, Rheumatology, EC, Committee, Colorectal cancer, Irinotecan, European Commission, Pharmaceutical industry, Vaccine, Tegafur/gimeracil/oteracil

In metastatic colorectal cancer, the typical first-line chemotherapy contains of a fluoropyrimidine used in various combinations.

Key Points: 
  • In metastatic colorectal cancer, the typical first-line chemotherapy contains of a fluoropyrimidine used in various combinations.
  • Jean-Michel Quinot, CEO of Nordic Pharma stated: "This is important news for patients with metastatic colorectal cancer.
  • Iris van Lakerveld, Global Oncology Lead added: "Fluoropyrimidines are, and will continue to be, the cornerstone of chemotherapy treatment in metastatic colorectal cancer.
  • This positive CHMP opinion is a first step in providing patients with metastatic colorectal cancer access to Teysuno.

Global Flue Gas Desulfurization (FGD) Systems Market 2021-2026 - $24.9 Billion Opportunity Assessment by Type, End-use Industry, Installation, and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 29, 2021
Other Manufacturing, Manufacturing, Growth, European Committee for Standardization, Engineering, FGD, CAGR, Electricity, United States Environmental Protection Agency, Region, Plant, Wet, Federation, USD, International Energy Agency, Organization, Bangladesh Cement Manufacturers Association, Coal, Awareness, Adoption, Government, Greenfield, Air pollution, Industry, Renewable energy

The global FGD systems market is projected to grow from USD 19.3 billion in 2021 to USD 24.9 billion by 2026, at a CAGR of 5.2% from 2021 to 2026.

Key Points: 
  • The global FGD systems market is projected to grow from USD 19.3 billion in 2021 to USD 24.9 billion by 2026, at a CAGR of 5.2% from 2021 to 2026.
  • Based on type, the FGD systems market has been classified into wet and dry & semi-dry.
  • The FGD systems market in Asia Pacific is projected to grow at the highest CAGR from 2021 to 2026.
  • The report defines, segments, and projects the size of the FGD systems market based on type, end-use industry, installation, and region.

Global Healthcare Personal Protective Equipment (PPE) Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 17, 2021
Medical Supplies, Health, Hospital, FDA, Lists of countries and territories, Growth, EC, Industry, PPE, European Committee for Standardization, European Commission, CAGR, Hygiene, Prevalence, N95 respirator, COVID-19, CEN, Royal commission, Organization, Personal protective equipment, N95

The "Global Healthcare Personal Protective Equipment Market Size, Share & Trends Analysis Report by Product (Respiratory, Hand Protection), by End-use (Hospitals, Outpatient/Primary Care Facilities), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Healthcare Personal Protective Equipment Market Size, Share & Trends Analysis Report by Product (Respiratory, Hand Protection), by End-use (Hospitals, Outpatient/Primary Care Facilities), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The high prevalence of Covid-19, especially in North America and Europe, is expected to drive the product demand throughout 2021.
  • Increased product demand due to the global pandemic ultimately strained the supply chain, thereby creating a shortage in the market.
  • However, with the manufacturers increasing their production capacities and several industry participants pivoting their production from their usual products to personal protective equipment (PPE), the supply chain has improved over the past few months.